STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today ...
A hybrid vector of adeno-associated virus and phage (termed AAVP) has been introduced as a platform for systemic ligand-directed delivery of transgenes to tumors over the past decade. A series of ...
Every vector system currently available for gene therapy has some drawbacks and advantages. 1 The use of viral vectors such as retroviral and lentiviral vectors allow for the improved duration of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results